CONMED CORPORATION Increase (Decrease) in Accounts Receivable from Securitization
CONMED CORPORATION (CNMD) reported Increase (Decrease) in Accounts Receivable from Securitization of $0 for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableFromSecuritization · last filed 2013-02-25
- CONMED CORPORATION increase (decrease) in accounts receivable from securitization for the quarter ending 2011-12-31 was $0.00.
- CONMED CORPORATION increase (decrease) in accounts receivable from securitization for the quarter ending 2011-09-30 was $0.00, a 100.00% decline year-over-year.
- CONMED CORPORATION increase (decrease) in accounts receivable from securitization for the quarter ending 2010-12-31 was $0.00.
- CONMED CORPORATION increase (decrease) in accounts receivable from securitization for the quarter ending 2010-09-30 was $58.00M.
- CONMED CORPORATION increase (decrease) in accounts receivable from securitization for fiscal 2012 was $0.00.
- CONMED CORPORATION increase (decrease) in accounts receivable from securitization for fiscal 2011 was $0.00, a 100.00% decline from fiscal 2010.
- CONMED CORPORATION increase (decrease) in accounts receivable from securitization for fiscal 2010 was $29.00M, a 123.08% increase from fiscal 2009.
- CONMED CORPORATION increase (decrease) in accounts receivable from securitization for fiscal 2009 was $13.00M.
| Period end | Increase (Decrease) in Accounts Receivable from Securitization 3 month | Increase (Decrease) in Accounts Receivable from Securitization 6 month | Increase (Decrease) in Accounts Receivable from Securitization 9 month | Increase (Decrease) in Accounts Receivable from Securitization 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 10-K · filed 2013-02-25 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-25 | $0.00 derived: sum of 2 quarters · filed 2013-02-25 | $0.00 10-K · filed 2013-02-25 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 | $0.00 10-Q · filed 2011-11-01 | ||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-09 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-25 | $58.00M derived: sum of 2 quarters · filed 2013-02-25 | $29.00M 10-K · filed 2013-02-25 | |
| 2010-09-30 | $58.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 | $29.00M 10-Q · filed 2011-11-01 | ||
| 2010-06-30 | -$29.00M 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $13.00M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |